Literature DB >> 19500241

Microparticle-associated tissue factor activity in cancer patients with and without thrombosis.

M E T Tesselaar, F P H T M Romijn, I K van der Linden, R M Bertina, S Osanto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19500241     DOI： 10.1111/j.1538-7836.2009.03504.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  53 in total

Review 1.  Thrombosis and cancer.

Authors:  Annie Young; Oliver Chapman; Carole Connor; Christopher Poole; Peter Rose; Ajay K Kakkar
Journal:  Nat Rev Clin Oncol       Date:  2012-07-10       Impact factor: 66.675

Review 2.  The Platelet Lifeline to Cancer: Challenges and Opportunities.

Authors:  Monika Haemmerle; Rebecca L Stone; David G Menter; Vahid Afshar-Kharghan; Anil K Sood
Journal:  Cancer Cell       Date:  2018-04-12       Impact factor: 31.743

3.  The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.

Authors:  Katrin F Nickel; Göran Ronquist; Florian Langer; Linda Labberton; Tobias A Fuchs; Carsten Bokemeyer; Guido Sauter; Markus Graefen; Nigel Mackman; Evi X Stavrou; Gunnar Ronquist; Thomas Renné
Journal:  Blood       Date:  2015-07-07       Impact factor: 22.113

Review 4.  Mouse models of cancer-associated thrombosis.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Thromb Res       Date:  2017-12-29       Impact factor: 3.944

5.  Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner.

Authors:  Jian-Guo Wang; Julie C Williams; Beckley K Davis; Ken Jacobson; Claire M Doerschuk; Jenny P-Y Ting; Nigel Mackman
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

Review 6.  Microparticle analysis in disorders of hemostasis and thrombosis.

Authors:  Micah J Mooberry; Nigel S Key
Journal:  Cytometry A       Date:  2015-02-20       Impact factor: 4.355

7.  Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.

Authors:  R D Lee; D A Barcel; J C Williams; J G Wang; J C Boles; D A Manly; N S Key; N Mackman
Journal:  Thromb Res       Date:  2011-07-06       Impact factor: 3.944

8.  Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.

Authors:  J E Geddings; Y Hisada; Y Boulaftali; T M Getz; M Whelihan; R Fuentes; R Dee; B C Cooley; N S Key; A S Wolberg; W Bergmeier; N Mackman
Journal:  J Thromb Haemost       Date:  2015-12-11       Impact factor: 5.824

9.  Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).

Authors:  Jeffrey I Zwicker; Howard A Liebman; Kenneth A Bauer; Thomas Caughey; Federico Campigotto; Rachel Rosovsky; Simon Mantha; Craig M Kessler; Jonathan Eneman; Vidya Raghavan; Heinz-Joseph Lenz; Andrea Bullock; Elizabeth Buchbinder; Donna Neuberg; Bruce Furie
Journal:  Br J Haematol       Date:  2012-12-13       Impact factor: 6.998

Review 10.  Biomolecular markers of cancer-associated thromboembolism.

Authors:  Diana L Hanna; Richard H White; Ted Wun
Journal:  Crit Rev Oncol Hematol       Date:  2013-03-21       Impact factor: 6.312
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.